Skip to main content

Search articles in News

Found 2,761 articles

  • Top 10 Global Pharmaceutical Companies by Projecte

    Top 10 Global Pharmaceutical Companies by Projected R&D Spend 2026

    • 24 Jul 2024
    • Lucy Walters

    After what has been a challenging couple of years for the industry, many of the world’s leading life sciences companies are showing promising signs of recovery, with robust product pipelines and gastronomical investments being committed to researching and developing new and existing treatments.

  • Xeltis appoints Shawn Gage as Vice President of US

    Xeltis appoints Shawn Gage as Vice President of US Clinical Affairs

    • 24 Jul 2024
    • Editor

    Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces that it has appointed Shawn Gage as its new Vice President of US Clinical Affairs.

  • ramarketing Becomes the First Fully AI-Empowered L

    ramarketing Becomes the First Fully AI-Empowered Life Science Marketing Agency in the UK and North America

    • 24 Jul 2024
    • Editor

    ramarketing this week announced that it has become the first fully AI-empowered life science marketing agency in the UK and North America.

  • What Does a Chemist Do?

    What Does a Chemist Do?

    • 23 Jul 2024
    • Lucy Walters

    Chemists play a crucial role in the life sciences industry by contributing to various aspects of research and development. In drug development, chemists are responsible for designing, synthesising, and analysing new drugs. They collaborate with scientists and technicians to conduct experiments, analyse data, and develop new products or technologies in laboratories.

  • Caidya Announces Leadership Transition: Barbara Lo

    Caidya Announces Leadership Transition: Barbara Lopez Kunz Named CEO

    • 23 Jul 2024
    • Editor

    Caidya, a leading global provider of clinical trial solutions, is pleased to announce a transition in its executive leadership. Barbara Lopez Kunz, a distinguished member of the Caidya Board of Directors, will assume the role of Chief Executive Officer effective September 1, 2024.

  • Vividion Therapeutics to Expand with New Global Re

    Vividion Therapeutics to Expand with New Global Research and Development Center

    • 23 Jul 2024
    • Editor

    New facility in San Diego will support continued development of Vividion’s global discovery and clinical portfolio and pave the way for future programs aimed at bringing first-in-class therapeutics to patients in need / Chemoproteomics screening capacity will increase by 50 percent to enable Vividion to pursue an expansive range of previously undrugged disease targets

  • Gilead and the Elton John AIDS Foundation Announce

    Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central Asia

    • 22 Jul 2024
    • Editor

    Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John AIDS Foundation (EJAF) today announced a five-year extension of the RADIAN ® partnership to help meet the needs of the most vulnerable key populations in Eastern Europe and Central Asia (EECA) where the HIV epidemic is growing.

  • Envision Pharma Group launches 4Sight to drive AI

    Envision Pharma Group launches 4Sight to drive AI and technology performance in healthcare

    • 19 Jul 2024
    • Editor

    Leading global technology solutions partner Envision Pharma Group (Envision) has launched 4Sight, a new AI and technology-enabled approach designed to help medical affairs teams optimize raw data and turn it into actionable insights for healthcare professionals.

  • Danaher Announces Two New Centers of Innovation in

    Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development

    • 18 Jul 2024
    • Editor

    Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced the launch of two new Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified labs intended to accelerate the development of Companion Diagnostics (CDx) and Complementary Diagnostics (CoDx).

  • Chief Medical Officer Merdad Parsey to Leave Gilea

    Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025

    • 18 Jul 2024
    • Editor

    Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Chief Medical Officer Merdad Parsey, MD, PhD, will leave the company early next year. While the company works to identify a successor, Dr. Parsey will continue as Chief Medical Officer until the first quarter of 2025 and support this transition over the next several months.

  • The Impact of AI on Pharmaceutical R&D and Drug Di

    The Impact of AI on Pharmaceutical R&D and Drug Discovery

    • 17 Jul 2024
    • Lucy Walters

    The future of drug discovery and pharmaceutical research and development is being reshaped by artificial intelligence (AI), heralding a new era of speed, efficiency, and precision. AI’s potential to accelerate drug development, from molecular prediction to optimised design and improved clinical trials, promises to significantly cut costs and time-to-market for new medications.

  • Nouscom Appoints Tiffany Muller as Chief Financial

    Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice President, Technical and CMC Development

    • 17 Jul 2024
    • Editor

    Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, today announces the promotion of Tiffany Muller to Chief Financial Officer (CFO) and Loredana Siani, Ph.D., to Senior Vice President (SVP), Technical and CMC Development.

  • Insider's Guide to Hiring a Scientist

    Insider's Guide to Hiring a Scientist

    • 16 Jul 2024
    • Lucy Walters

    In this recruiter guide, we explore the essential considerations for you to remember when hiring a Scientist. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you focus your candidate search and engage your target audience of talent.

  • Step by Step Guide to Hiring a Scientist

    Step by Step Guide to Hiring a Scientist

    • 16 Jul 2024
    • Lucy Walters

    In this recruiter guide, we explore the essential considerations for you to remember when hiring a Scientist. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you focus your candidate search and engage your target audience of talent.

  • How to Hire a Scientist

    How to Hire a Scientist

    • 16 Jul 2024
    • Lucy Walters

    In this recruiter guide, we explore the essential considerations for you to remember when hiring a Scientist. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will help you focus your candidate search and engage your target audience of talent.

  • Stryker completes acquisition of Artelon, Inc.

    Stryker completes acquisition of Artelon, Inc.

    • 16 Jul 2024
    • Editor

    Stryker (NYSE: SYK), a global leader in medical technologies, has completed the previously announced acquisition of Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures.

  • Acquisition of Amolyt Pharma completed

    Acquisition of Amolyt Pharma completed

    • 15 Jul 2024
    • Editor

    AstraZeneca today announced the successful completion of the acquisition of Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases.

  • Danaher Launches Beacon Research Collaboration wit

    Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening

    • 12 Jul 2024
    • Editor

    Danaher Corporation (NYSE: DHR), a global science and technology innovator, today launched a research collaboration with Stanford University's Department of Bioengineering intended to shape the future of cancer drug screening through "smart microscopy."

  • Thermo Fisher Scientific to Help Advance Myeloid C

    Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology

    • 12 Jul 2024
    • Editor

    To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.

  • Labcorp and Naples Comprehensive Healthcare Announ

    Labcorp and Naples Comprehensive Healthcare Announce Strategic Agreement for Lab Operations

    • 12 Jul 2024
    • Editor

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has entered into a comprehensive strategic collaboration with Naples Comprehensive Healthcare (NCH) in Southwest Florida to manage the daily operations of NCH’s inpatient lab operations. Separately, Labcorp will begin to serve as the primary lab for NCH’s physician network later this summer.